Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q3 2020 13F Holders as of 30 Sep 2020
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,223,539
- Total 13F value
- $39,457,000
- Share change
- +100,806
- SEC-reported price per share
- $6.34
- Number of holders
- 9
- Value change
- +$654,975
- Number of buys
- 2
- Number of sells
- 3
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
Who this page is about.
1 source field
Report period
Q3 2020
Institutions
9
Top holders
9
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2020
Previous quarter: Q2 2020
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
12/12
Latest evidence
30 Jun 2020
13F
Lead comparable stake: 146%
Showing 1-6 of 12 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 146%.
12 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
146%
Johnson & Johnson Innovation - JJ...
134%
MMCAP International Inc. SPC
43%
RTW INVESTMENTS, LP
38%
MILLENNIUM MANAGEMENT LLC
19%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
146%
|
$12,770,000
2,313,489 shares
|
— | 30 Jun 2020 |
| Johnson & Johnson Innovation - JJDC, Inc. |
13F
Company
|
134%
|
$11,776,000
2,133,402 shares
|
— | 30 Jun 2020 |
| MMCAP International Inc. SPC |
13F
Company
|
43%
|
$3,778,000
684,451 shares
|
— | 30 Jun 2020 |
| RTW INVESTMENTS, LP |
13F
Company
|
38%
|
$3,312,000
600,000 shares
|
— | 30 Jun 2020 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
19%
|
$1,632,000
295,615 shares
|
— | 30 Jun 2020 |
| Taylor Wealth Management Partners |
13F
Company
|
2.7%
|
$240,000
43,552 shares
|
— | 30 Jun 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
9
Shares
6,223,539
Rows available
9
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
12
Q3 2020 holders
9
Holder diff
-3
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 value | Q3 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend